Markets Share Share this article Copy linkX (Twitter)LinkedInFacebookEmail Tokenization 'supercycle' set to drive crypt Markets Share Share this article Copy linkX (Twitter)LinkedInFacebookEmail Tokenization 'supercycle' set to drive crypt

Tokenization 'supercycle' set to drive crypto’s next leg higher in 2026: Bernstein

Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail

Tokenization 'supercycle' set to drive crypto’s next leg higher in 2026: Bernstein

After a choppy end to 2025, Wall Street broker Bernstein said crypto markets have likely bottomed and it sees a broad-based tokenization boom reshaping finance.

By Will Canny, AI Boost|Edited by Jamie Crawley
Jan 7, 2026, 4:12 p.m.
Make us preferred on Google
Tokenization 'supercycle' set to drive crypto’s next leg higher in 2026: Bernstein. (Unsplash, modified by CoinDesk)

What to know:

  • Bernstein expects a tokenization 'supercycle' in 2026 spanning stablecoins, capital markets and prediction markets.
  • The broker reiterated its $150,000 bitcoin forecast for 2026 and $200,000 as its peak 2027 cycle target.
  • Coinbase, Robinhood and other crypto-linked equities are seen as key beneficiaries.

Wall Street broker Bernstein said 2026 is likely to mark the start of a tokenization “supercycle,” with digital assets having probably bottomed after a weak end to 2025, making market dips an opportunity to add exposure to crypto-linked stocks.

The broker says sentiment weakened late last year but underlying fundamentals remain intact, analysts led by Gautam Chhugani wrote in a Tuesday report.

STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
Sign me up

Bernstein maintained its bitcoin BTC$91,302.38 forecast of $150,000 in 2026, with a $200,000 target for the peak of the next market cycle in 2027.

The world's largest cryptocurrency was trading around $91,600 at publication time.

While bitcoin finished 2025 down about 6%, the report noted that crypto equities delivered their strongest year on record, with average returns of roughly 59% despite a fourth-quarter cooldown..

Outperform-rated Robinhood (HOOD), Coinbase (COIN), Figure (FIGR) and Circle (CRCL) are the "best tokenization proxies" with the firm's coverage, according to the report.

The analysts cut their Circle price target to $190 from $230. The shares were 4% lower in early trading at $81.35. The broker also reduced its Coinbase price target to $440 from $510. The stock was 3.3% lower at $242.62.

The next phase of growth will be driven by tokenization across multiple fronts, the analysts said.

Stablecoins, in particular, are seen moving beyond crypto trading into mainstream banking and payments. The analysts expect total supply to rise 56% year-over-year to about $420 billion by 2026, supported by cross-border business payments, consumer remittances, stablecoin-based neobanks and so-called agentic payments.

Stablecoins are cryptocurrencies pegged to assets like fiat currencies or gold. They underpin much of the crypto economy, serving as payment rails and a tool for moving money across borders. USDT is the largest stablecoin, followed by USDC.

Bernstein pointed to growing adoption by fintech firms such as Block (XYZ), Revolut and PayPal (PYPL), as well as the expansion of agent payment protocols like Coinbase-built X402, which is already tracking roughly $300 million in annualized transaction volume.

Tokenization, the process by which real-world assets are converted into blockchain-based tokens, is another major pillar of the analysts' thesis. They estimated that onchain value locked in tokenized assets could more than double, from around $37 billion in 2025 to about $80 billion in 2026.

Prediction markets round out the firm's tokenization outlook. The broker projects total volumes could grow by 100% in 2026 to roughly $70 billion, implying about $1.4 billion in annual revenue for market makers and exchanges based on average contract fees

Read more: Citi is still a believer in crypto stocks despite bitcoin being rocked to end the year

TokenizationStablecoinsCoinbaseCircleBernstein
AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

KuCoin Hits Record Market Share as 2025 Volumes Outpace Crypto Market

Commissioned byKuCoin

KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.

What to know:

  • KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.
  • This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.
  • Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.
  • Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.
  • Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.
View Full Report

More For You

Experts tip privacy tokens to continues outperforming in 2026

Analysts believe privacy tokens such as zcash and monero will continue to outperform this year, but they will likely face delisting risks and conflicts with banks over regulatory issues.

What to know:

  • Privacy-focused cryptocurrencies have outperformed the market, driven by increasing demand for financial anonymity amid tightening regulations.
  • Analysts warn that while privacy coins are gaining traction, they face significant regulatory challenges that could impact future gains.
  • The trend towards privacy in crypto is expected to continue, with privacy-preserving systems becoming more essential as blockchain adoption grows in regulated environments.
Read full story
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26